Inovio Biomedical Corp. (INO)

zzlangerhans (99.52) Submitted: 11/20/2009 4:18:09 PM : Start Price: $1.52 INO Score: +10.65

The newfound value of Inovio follows from their merger with VGX and their DNA vaccine technology, and the fortuitous (for them) occurrence of the H1N1 epidemic. As long as this epidemic remains hot news, Inovio stock will shoot upward with the slightest hint of progress in their technology. Today's burst was due to more reprots about protective immunity in animal studies. In case you weren't reading closely, that's preclinical. Even Inovio CEO J. Joseph Kim admits in a street.com interview that the project is in early stages. "We're not going to have a product on the shelf this fall," he said. "But the power of our approach -- we're going to be there when these other traditional approaches fail." Maybe. But when this epidemic is history, so will be Inovio over 1. Fortunately the company took advantage of the initial irrational burst of dilution to cash in with a sweet dilutive financing which will keep them around for quite a while. Nice move on that merger, Inovio.

pfenix (< 20) Submitted: 11/20/2009 1:09:23 PM : Start Price: $1.53 INO Score: -11.15

flu vaccine not based on old outdated viruses...uses DNA to fight viruses naturally

cecamadocv (98.76) Submitted: 11/20/2009 10:27:53 AM : Start Price: $1.53 INO Score: +11.05

I think this company is a scam, everyday they have a press release of some bullsh*t.

Usually its we have a cure for aids, or we have the answer for world peace...

croc of shi* i tell you

usmcnoob (< 20) Submitted: 8/21/2009 7:12:59 PM : Start Price: $2.02 INO Score: -39.43

Once they get FDA approval, this stock should soar. Just hope that they get FDA approval...

PCSCRZY (< 20) Submitted: 8/11/2009 12:12:20 PM : Start Price: $1.91 INO Score: -40.93

THEIR MARKET PICKING UP

cez4me (< 20) Submitted: 8/10/2009 6:09:42 PM : Start Price: $2.28 INO Score: -50.34

They are or should be a part of the H1N1 ordeal and begin a turn around in the next 2 weeks possibly a few months. Depending on the severity of the H1N1 Virus.

STOCKEEPER (< 20) Submitted: 8/5/2009 4:35:11 PM : Start Price: $2.40 INO Score: -53.08

1)AUG 1 2009 WINE FLU RESULTS CAME IN AT 100 % DEFEATED WHEN IT WAS INJECTED INTO THE PIGS..

2) AUG 5 2009 SUPPIRISE THE COMPANY HAS A PIPE LINE OF SUCCESS AS THE NEW FOR TODAY STATES THE CANCER CLINICAL STUDIES ARE ALSO
LAMDMARK RESILTS..

ITS BIOTECH TIME UNITL THE BULL MARKET APPEARS..AND THAT WONT BE FOR 1 OR 2 YEARS
UNTIL THE ELECTRIC VEHICLE IS CHEAPER AND MORE EFFECIENT...

AND THE HEALTH CARE PROBLEM IS PUT TO BED
BY MAKING THE YOUNGER AND ADLUT GENERATION HAVE MANDITORY HEALTH INSURANCE FOR BYCICLES /SKATE BOARDS ETC..

Francorp (< 20) Submitted: 8/1/2009 12:23:03 AM : Start Price: $2.36 INO Score: -53.15

Swine Flu Pandemic is a major issue right now, not enough supply, INO is one of the few companies that has a viable vaccine that could be used to stop H1N1. Here is a recent release from Reuters:
The U.S. Health and Human Services Department declared a public health emergency over swine flu in April, giving the Food and Drug Administration the power to allow the use of unapproved medical products including adjuvants. The health department agreed to purchase more than $415 million of the vaccine additives, while saying it may not use them if enough shots are available for U.S. residents
INO also recently sold 30 million worth of shares to institutional investors for working capital, the shares were priced at 2.70/share. Current price today is 2.09. This is an easy 25-30% gain over the next week, possibly a 100% gain if we see some continued positive news about the organization.

Polarimetric (86.34) Submitted: 7/31/2009 4:12:08 PM : Start Price: $2.36 INO Score: -53.15

Currently a loss-maker and definitely a stock that displays the usual volatility and soar-and-crash patterns of biomedical stocks, but the long-term potential here is massive. Inovio's working on some serious stuff, and they are truly the first company to debut a practical platform for a swine flu vaccine. If they can get it to work, sales for Q4 and beyond are going to be a knockout.

8tune (64.63) Submitted: 7/31/2009 11:52:02 AM : Start Price: $2.27 INO Score: -51.95

INO is developing vacinnes against A/H1N1 and Dengue fever.

lttuvok (< 20) Submitted: 7/31/2009 9:35:18 AM : Start Price: $1.69 INO Score: -21.76

Fears of a pandemic will keep this stock rising.

TMFStockPick07 (< 20) Submitted: 5/22/2007 12:33:57 PM : Start Price: $4.14 INO Score: -43.54

This stock was picked to outperform from May 2007 to May 2008 by TMFJbP

maoy (< 20) Submitted: 4/25/2007 1:03:28 PM : Start Price: $3.89 INO Score: -43.41

A hunch... :-)

fullwealth (97.64) Submitted: 4/23/2007 3:53:19 PM : Start Price: $3.75 INO Score: -42.42

TS - great new products